VAL-0411

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVAL-0411

Drug Alias Name3E10Fv-MBNL1 protein therapy (4s3 Bioscience)MBNL1-antibody conjugate (4s3)4s3-002VAL-0411

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine +[4]

Mechanisms of ActionMuscleblind-like protein 1 stimulants

TargetsMuscleblind-like protein 1

Therapy Area/IndicationsMyotonic Dystrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesValerion Therapeutics Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesValerion Therapeutics Llc

Active IndicationsN/A

Inactive IndicationsMyotonic Dystrophy

Other Information

ATC CodeN/A